# Combined Treatment of Minocycline and Lovastatin to Treat Individuals With Fragile X Syndrome

> **NCT02680379** · PHASE2 · COMPLETED · sponsor: **Université de Sherbrooke** · enrollment: 22 (actual)

## Conditions studied

- Fragile X Syndrome

## Interventions

- **DRUG:** Minocycline, then Minocycline/Lovastatin
- **DRUG:** Lovastatin, then Minocycline/Lovastatin

## Key facts

- **NCT ID:** NCT02680379
- **Lead sponsor:** Université de Sherbrooke
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2017-10
- **Final completion:** 2017-11
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2018-10-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02680379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02680379, "Combined Treatment of Minocycline and Lovastatin to Treat Individuals With Fragile X Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02680379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*